The Gap in Integrated Pediatric Care: A Systematic Review of Family-Based Weight Management for Children Living with

Joshua S Yudkin1, Christopher Owens1, James Gilbreath2

  • 1Texas A&M University, USA.

Sage Open Pediatrics
|February 23, 2026
PubMed

Insights

Children with HIV face growing obesity risks due to weight-gaining medications. A global review found no family-based weight management programs integrated into pediatric HIV care, highlighting a critical research gap.

Area of Science:

  • Pediatric HIV care
  • Obesity management
  • Implementation science

Background:

  • Children with HIV (CWH) face a "double burden" of infectious and non-communicable diseases, including overweight and obesity (OW/OB).
  • Weight-inducing Integrase Strand Transfer Inhibitors (INSTIs) used in HIV treatment exacerbate OW/OB risk in CWH.
  • Pediatric OW/OB is a growing concern for CWH with increased life expectancy.

Purpose of the Study:

  • To systematically review family-based pediatric weight management interventions for CWH aged 6 to 12 globally.
  • To identify existing evidence-based behavioral support for CWH experiencing OW/OB.
  • To address the emerging challenge of pediatric overweight and obesity in children living with HIV.

Main Methods:

  • Systematic literature review following PRISMA guidelines.
  • Searched Medline, Embase, and Cochrane databases from 2007 to 2024.
  • Included clinic-linked behavioral interventions reporting body composition or behavioral outcomes.

Main Results:

  • No studies met the inclusion criteria for family-based pediatric weight management interventions for CWH.
  • 1026 records and 7 full-text reviews were screened.
  • Excluded studies lacked clinical integration or targeted adult populations.

Conclusions:

  • A critical evidence gap exists regarding weight management support for CWH on weight-inducing medications.
  • There is an urgent need for evidence-based behavioral interventions for pediatric overweight and obesity in CWH.
  • Future research should focus on integrating HIV primary care and obesity management using implementation science frameworks, especially in resource-constrained settings.
Abstract

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.4K
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
303
Community Based Intervention01:30

Community Based Intervention

Community-based interventions in mental health represent a paradigm shift from institution-centered care to treatments embedded within the fabric of local communities. By prioritizing inclusion and leveraging existing societal structures, this approach fosters a supportive environment conducive to addressing mental health challenges while promoting individual dignity and agency.
Foundations of Community Mental Health Programs
Central to the success of community-based interventions is the...
518
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
303
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
1.2K
Parentral Nutrition: Centeral and Peripheral Parental Nutrition01:27

Parentral Nutrition: Centeral and Peripheral Parental Nutrition

Parenteral Nutrition (PN) delivers essential nutrients directly into the bloodstream, bypassing the digestive system. It is commonly used for individuals with severe digestive disorders or conditions that prevent normal nutrient absorption.
PN can be administered through two primary routes:
1. Central Parenteral Nutrition (CPN):
CPN involves delivering a high concentration of nutrients through a large vein. This is typically achieved using a Peripherally Inserted Central Catheter (PICC) or,...
1.1K